132 related articles for article (PubMed ID: 10992163)
1. Advances in neurofibromatosis 2 (NF2): a workshop report.
Lim DJ; Rubenstein AE; Evans DG; Jacks T; Seizinger BG; Baser ME; Beebe D; Brackmann DE; Chiocca EA; Fehon RG; Giovannini M; Glazer R; Gusella JF; Gutmann DH; Korf B; Lieberman F; Martuza R; McClatchey AI; Parry DM; Pulst SM; Ramesh V; Ramsey WJ; Ratner N; Rutkowski JL; Ruttledge M; Weinstein DE
J Neurogenet; 2000 Jun; 14(2):63-106. PubMed ID: 10992163
[No Abstract] [Full Text] [Related]
2. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.
Parry DM; MacCollin MM; Kaiser-Kupfer MI; Pulaski K; Nicholson HS; Bolesta M; Eldridge R; Gusella JF
Am J Hum Genet; 1996 Sep; 59(3):529-39. PubMed ID: 8751853
[TBL] [Abstract][Full Text] [Related]
3. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
4. Mouse models of neurofibromatosis 1 and 2.
Gutmann DH; Giovannini M
Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2.
Chan CC; Koch CA; Kaiser-Kupfer MI; Parry DM; Gutmann DH; Zhuang Z; Vortmeyer AO
J Pathol; 2002 Sep; 198(1):14-20. PubMed ID: 12210058
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis 2 in the pediatric age group.
Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
[TBL] [Abstract][Full Text] [Related]
7. The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts.
Pykett MJ; Murphy M; Harnish PR; George DL
Hum Mol Genet; 1994 Apr; 3(4):559-64. PubMed ID: 8069298
[TBL] [Abstract][Full Text] [Related]
8. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
[TBL] [Abstract][Full Text] [Related]
9. Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
Feucht M; Kluwe L; Mautner VF; Richard G
Arch Ophthalmol; 2008 Oct; 126(10):1376-80. PubMed ID: 18852415
[TBL] [Abstract][Full Text] [Related]
10. Unilateral vestibular schwannoma and meningiomas in a patient with PIK3CA-related segmental overgrowth: Co-occurrence of mosaicism for 2 rare disorders.
Mills JR; Moyer AM; Kipp BR; Poplawski AB; Messiaen LM; Babovic-Vuksanovic D
Clin Genet; 2018 Jan; 93(1):187-190. PubMed ID: 28737257
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 2.
Asthagiri AR; Parry DM; Butman JA; Kim HJ; Tsilou ET; Zhuang Z; Lonser RR
Lancet; 2009 Jun; 373(9679):1974-86. PubMed ID: 19476995
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis 2: a clinically and genetically heterogeneous disease? Report on 10 sporadic cases.
Mayfrank L; Wullich B; Wolff G; Finke J; Gouzoulis E; Gilsbach JM
Clin Genet; 1990 Nov; 38(5):362-70. PubMed ID: 2282716
[TBL] [Abstract][Full Text] [Related]
13. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis 2.
Hoa M; Slattery WH
Otolaryngol Clin North Am; 2012 Apr; 45(2):315-32, viii. PubMed ID: 22483819
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 2.
Slattery WH
Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
[TBL] [Abstract][Full Text] [Related]
16. An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2).
Evans DG; Wallace A
J Med Genet; 2009 Nov; 46(11):792. PubMed ID: 19880713
[No Abstract] [Full Text] [Related]
17. Neurofibromatosis 2.
Baser ME; R Evans DG; Gutmann DH
Curr Opin Neurol; 2003 Feb; 16(1):27-33. PubMed ID: 12544854
[TBL] [Abstract][Full Text] [Related]
18. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
[TBL] [Abstract][Full Text] [Related]
20. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF
Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
